Cynaropicrin: Difference between revisions
Content deleted Content added
link to review of bioactivities |
pmid using AWB (12130) |
||
Line 30: | Line 30: | ||
}} |
}} |
||
'''Cynaropicrin''' is a [[sesquiterpene lactone]]<ref>{{cite journal | pmid= 14706635 | title = Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions | volume=313 | issue=4 | date=January 2004 | journal=Biochem. Biophys. Res. Commun. | pages=954–61 | doi=10.1016/j.bbrc.2003.12.026}}</ref> exhibiting a range of diverse bioactivities.<ref>Elsebai MF |
'''Cynaropicrin''' is a [[sesquiterpene lactone]]<ref>{{cite journal | pmid= 14706635 | title = Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions | volume=313 | issue=4 | date=January 2004 | journal=Biochem. Biophys. Res. Commun. | pages=954–61 | doi=10.1016/j.bbrc.2003.12.026}}</ref> exhibiting a range of diverse bioactivities.<ref>{{cite journal |last1=Elsebai |first1=MF |last2=Mocan |first2=A |last3=Atanasov |first3=AG |title=Cynaropicrin: A Comprehensive Research Review and Therapeutic Potential As an Anti-Hepatitis C Virus Agent |journal=Front Pharmacol |date=December 2016 |volume=8 |number=7 |page=472 |pmc=5143615 |pmid=28008316}}</ref> |
||
==References== |
==References== |
Revision as of 05:53, 3 January 2017
Names | |
---|---|
IUPAC name
[(3aR,4S,6aR,8S,9aR,9bR)-8-Hydroxy-3,6,9-trimethylidene-2-oxo-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] 2-(hydroxymethyl)prop-2-enoate
| |
Other names
Aguerin
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.216.734 |
KEGG | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H22O6 | |
Molar mass | 346.379 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Cynaropicrin is a sesquiterpene lactone[1] exhibiting a range of diverse bioactivities.[2]
References
- ^ "Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions". Biochem. Biophys. Res. Commun. 313 (4): 954–61. January 2004. doi:10.1016/j.bbrc.2003.12.026. PMID 14706635.
- ^ Elsebai, MF; Mocan, A; Atanasov, AG (December 2016). "Cynaropicrin: A Comprehensive Research Review and Therapeutic Potential As an Anti-Hepatitis C Virus Agent". Front Pharmacol. 8 (7): 472. PMC 5143615. PMID 28008316.